Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study-Reference-Cited by-同舟云学术

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study

Published:2017-11-30 Issue:1 Volume:2 Page:48-57
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Hagström Hannes¹²³,Nasr Patrik⁴,Ekstedt Mattias⁴,Hammar Ulf⁵,Stål Per¹⁶,Hultcrantz Rolf¹⁶,Kechagias Stergios⁴

Affiliation:

1. Center for Digestive Diseases, Division of HepatologyKarolinska University HospitalStockholm Sweden

2. Department of Medicine, HuddingeKarolinska InstituteStockholm Sweden

3. Clinical Epidemiology Unit, Department of MedicineSolna, Karolinska InstituteStockholm Sweden

4. Department of Gastroenterology and Hepatology, Department of Medical and Health SciencesLinköping UniversityLinköping Sweden

5. Unit of Biostatistics, Institute of Environmental Medicine, Karolinska InstituteStockholm Sweden

6. Department of Medicine and HuddingeKarolinska InstituteStockholm Sweden

Funder

Swedish Royal Academy of Sciences

Bengt Ihre scholarship

Swedish Gastroenterology Fund

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1124

Reference31 articles.

1. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008;Younossi ZM;Clin Gastroenterol Hepatol,2011

2. The global NAFLD epidemic;Loomba R;Nat Rev Gastroenterol Hepatol,2013

3. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort;Setiawan VW;Hepatology,2016

4. Global epidemiology of nonalcoholic fatty liver disease‐meta‐analytic assessment of prevalence, incidence, and outcomes;Younossi ZM;Hepatology,2016

5. Trends in adult body‐mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population‐based measurement studies with 19.2 million participants;Lancet,2016

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside;Journal of Clinical Medicine;2024-01-03

2. Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review;Translational Gastroenterology and Hepatology;2024-01

3. Fatty Liver Disease;MacSween's Pathology of the Liver;2024

4. Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity;2024-01

5. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis;Annals of Hepatology;2024-01